Daniel Busby

Stock Analyst at RBC Capital

(2.72)
# 2,079
Out of 5,012 analysts
6
Total ratings
66.67%
Success rate
22.25%
Average return

Stocks Rated by Daniel Busby

Verrica Pharmaceuticals
May 25, 2022
Downgrades: Sector Perform
Price Target: $160$40
Current: $4.61
Upside: +767.68%
Pfizer
Jun 17, 2021
Maintains: Sector Perform
Price Target: $43$44
Current: $26.27
Upside: +67.49%
MannKind
May 14, 2021
Initiates: Sector Perform
Price Target: $5
Current: $5.65
Upside: -11.50%
AbbVie
May 3, 2021
Reiterates: Outperform
Price Target: $135
Current: $232.83
Upside: -42.02%